Home » Topics » BioWorld Science

BioWorld Science
RSS

RAC1 predicts dabrafenib resistance in papillary thyroid cancer

Oct. 7, 2021

Thymosin beta4 reverses cognitive impairment in mouse model of AD

Oct. 7, 2021

THRB agonist reduces aggressive phenotype in anaplastic thyroid cancer

Oct. 7, 2021

VRDN-002 demonstrates promising PK profile in nonhuman primates

Oct. 7, 2021

Study of APOE3 gene variant points to APOE aggregation as a target for treating dementia

Oct. 7, 2021

Verge Analytics discovers new PIKfyve inhibitors

Oct. 7, 2021

Researchers synthesize new CDK inhibitors

Oct. 7, 2021

Zoetis Services identifies IL-1beta, IL-6 and TNF-alpha production inhibitors

Oct. 7, 2021

North China Pharmaceutical Group Semisyntech divulges GPX4 inhibitors

Oct. 7, 2021

Purdue Research Foundation patents PD-1/PD-L1 interaction inhibitors

Oct. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...